Compare Serentis vs XenoPort
Customers evaluate the quality of Serentis's products using the following success metrics.
Overview
Serentis is based in United Kingdom
Serentis is a biopharmaceutical company which aims to develop a pipeline of products to address unmet medical needs in the dermatology field. The company's strategy is to establish a clinical stage development pipeline by the reprofiling of existing drugs and through the licensing or acquisition of projects from external sources. This is an approach that Serentis' management team has successfully pursued in the past.
XenoPort is 25 yrs old and is based in United States.
XenoPort is a biopharmaceutical company. It develops a portfolio of internally discovered product candidates that utilize the body's natural nutrient transporter mechanisms to improve the therapeutic benefits of existing drugs. It was founded in 1999 and is based in Redwood City, California.
Demo Video
Leadership
Tim Sharpington (Chief Executive Officer)
Mark Gallop (Founder)
Investors
Novo Holdings, MVM Partners
Arbor Pharmaceuticals, Venrock
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Serentis has not claimed their profile.
Work for Serentis? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Serentis?
Claim your profile now.
Information not available because XenoPort has not claimed their profile.
Work for XenoPort? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for XenoPort?
Claim your profile now.